Overview

Cystic Fibrosis (CF) Exacerbation and Insulin Treatment

Status:
Unknown status
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate whether insulin treatment during pulmonary exacerbation (PE) in patients with Cystic Fibrosis (CF)and normoglycemia improves their short term outcome by normalizing the glycemic profile and enhancing recovery. the investigators would like to evaluate whether insulin treatment during exacerbation improves both the general clinical condition of these patients and also has a protecting effect on ß-cells by preventing the deleterious effect of "chronic" hyperglycemia.
Phase:
N/A
Details
Lead Sponsor:
Hadassah Medical Organization
Treatments:
Insulin
Insulin Aspart
Insulin Lispro
Insulin, Globin Zinc
Insulin, Short-Acting